成本效果分析中的生产力成本:分子还是分母——进一步讨论

Productivity costs in cost‐effectiveness analysis: numerator or denominator: a further discussion

Health Economics · 1997
被引 13
人大 A-

中文导读

回应Weinstein等人指出的Erasmus小组与美国专家小组在疾病期间生产力损失测量方法上的主要分歧,分析对个人、雇主和社会的不同影响,指出遵循美国专家小组建议会面临理论和实践困难。

Abstract

In this response we concentrate on what Weinstein et al. call the ‘major disagreement’ between the Erasmus group and the US Panel, which concerns the measurement of productivity losses during illness. We consider the consequences for the individual, for the employer and for the rest of society and argue that when following the Panel's propositions for measuring these consequences, major theoretical and practical difficulties are encountered. © 1997 John Wiley & Sons, Ltd.

生产力成本成本效果分析疾病生产力损失社会视角